Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer.
lung cancer
oncogenomics
personalized medicine
semiconductors
smart sensors
Journal
Pharmaceuticals (Basel, Switzerland)
ISSN: 1424-8247
Titre abrégé: Pharmaceuticals (Basel)
Pays: Switzerland
ID NLM: 101238453
Informations de publication
Date de publication:
22 Jul 2023
22 Jul 2023
Historique:
received:
08
06
2023
revised:
23
06
2023
accepted:
07
07
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
The therapeutic interventions against lung cancer are currently based on a fully personalized approach to the disease with considerable improvement of patients' outcome. Alongside continuous scientific progresses and research investments, massive technologic efforts, innovative challenges, and consolidated achievements together with research investments are at the bases of the engineering and manufacturing revolution that allows a significant gain in clinical setting. The scope of this review is thus to focus, rather than on the biologic traits, on the analysis of the precision sensors and novel generation materials, as semiconductors, which are below the clinical development of personalized diagnosis and treatment. In this perspective, a careful revision and analysis of the state of the art of the literature and experimental knowledge is presented. Novel materials are being used in the development of personalized diagnosis and treatment for lung cancer. Among them, semiconductors are used to analyze volatile cancer compounds and allow early disease diagnosis. Moreover, they can be used to generate MEMS which have found an application in advanced imaging techniques as well as in drug delivery devices. Overall, these issues represent critical issues only partially known and generally underestimated by the clinical community. These novel micro-technology-based biosensing devices, based on the use of molecules at atomic concentrations, are crucial for clinical innovation since they have allowed the recent significant advances in cancer biology deciphering as well as in disease detection and therapy. There is an urgent need to create a stronger dialogue between technologists, basic researchers, and clinicians to address all scientific and manufacturing efforts towards a real improvement in patients' outcome. Here, great attention is focused on their application against lung cancer, from their exploitations in translational research to their application in diagnosis and treatment development, to ensure early diagnosis and better clinical outcomes.
Sections du résumé
BACKGROUND AND RATIONALE
OBJECTIVE
The therapeutic interventions against lung cancer are currently based on a fully personalized approach to the disease with considerable improvement of patients' outcome. Alongside continuous scientific progresses and research investments, massive technologic efforts, innovative challenges, and consolidated achievements together with research investments are at the bases of the engineering and manufacturing revolution that allows a significant gain in clinical setting.
AIM AND METHODS
OBJECTIVE
The scope of this review is thus to focus, rather than on the biologic traits, on the analysis of the precision sensors and novel generation materials, as semiconductors, which are below the clinical development of personalized diagnosis and treatment. In this perspective, a careful revision and analysis of the state of the art of the literature and experimental knowledge is presented.
RESULTS
RESULTS
Novel materials are being used in the development of personalized diagnosis and treatment for lung cancer. Among them, semiconductors are used to analyze volatile cancer compounds and allow early disease diagnosis. Moreover, they can be used to generate MEMS which have found an application in advanced imaging techniques as well as in drug delivery devices.
CONCLUSIONS
CONCLUSIONS
Overall, these issues represent critical issues only partially known and generally underestimated by the clinical community. These novel micro-technology-based biosensing devices, based on the use of molecules at atomic concentrations, are crucial for clinical innovation since they have allowed the recent significant advances in cancer biology deciphering as well as in disease detection and therapy. There is an urgent need to create a stronger dialogue between technologists, basic researchers, and clinicians to address all scientific and manufacturing efforts towards a real improvement in patients' outcome. Here, great attention is focused on their application against lung cancer, from their exploitations in translational research to their application in diagnosis and treatment development, to ensure early diagnosis and better clinical outcomes.
Identifiants
pubmed: 37513953
pii: ph16071042
doi: 10.3390/ph16071042
pmc: PMC10385174
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Multidiscip Respir Med. 2020 Feb 19;15(1):36
pubmed: 32269772
N Engl J Med. 2005 Jun 23;352(25):2589-97
pubmed: 15972865
Front Pharmacol. 2023 Feb 21;14:1125547
pubmed: 36909198
Mater Sci Eng C Mater Biol Appl. 2018 Nov 1;92:489-495
pubmed: 30184774
Sci Transl Med. 2015 Apr 22;7(284):284ra57
pubmed: 25904741
Cell Mol Life Sci. 2005 Sep;62(18):2092-9
pubmed: 16132230
Ann Oncol. 2018 Jan 1;29(suppl_1):i10-i19
pubmed: 29462254
Int J Mol Sci. 2022 Jun 29;23(13):
pubmed: 35806230
J Breath Res. 2017 Jun 01;11(2):026006
pubmed: 28373602
Curr Clin Pharmacol. 2018;13(2):76-84
pubmed: 29992894
BMC Cancer. 2021 Mar 10;21(1):263
pubmed: 33691657
Respir Care. 2005 Sep;50(9):1161-76
pubmed: 16122400
Nat Med. 2021 Aug;27(8):1345-1356
pubmed: 34385702
N Engl J Med. 2017 Nov 16;377(20):1919-1929
pubmed: 28885881
Nature. 2007 Mar 8;446(7132):153-8
pubmed: 17344846
J Am Chem Soc. 2004 Sep 29;126(38):11752-3
pubmed: 15382884
Sensors (Basel). 2019 Oct 29;19(21):
pubmed: 31671739
Int J Environ Res Public Health. 2022 Nov 09;19(22):
pubmed: 36429453
Br J Cancer. 2018 May;118(11):1492-1501
pubmed: 29765148
Lancet Oncol. 2017 Jan;18(1):31-41
pubmed: 27932067
South Asian J Cancer. 2021 Dec 20;10(3):175-182
pubmed: 34938681
Int Immunopharmacol. 2022 Jan;102:108353
pubmed: 34883352
BMC Med. 2018 Oct 2;16(1):166
pubmed: 30285732
Clin Transl Oncol. 2019 Oct;21(10):1287-1301
pubmed: 30864018
Clin Cancer Res. 2003 Sep 15;9(11):4227-39
pubmed: 14519650
Int J Mol Sci. 2021 Aug 20;22(16):
pubmed: 34445720
Sci Rep. 2022 Oct 27;12(1):18063
pubmed: 36302939
J Thorac Cardiovasc Surg. 2010 Feb;139(2):366-78
pubmed: 20106398
ACS Biomater Sci Eng. 2023 May 8;9(5):2806-2815
pubmed: 37079915
J Pharm Pharmacol. 2016 May;68(5):556-78
pubmed: 27061412
Adv Healthc Mater. 2019 Feb;8(3):e1801054
pubmed: 30565887
Lancet Oncol. 2021 Feb;22(2):198-211
pubmed: 33476593
J Drug Target. 2022 Mar;30(3):269-286
pubmed: 34595987
Cell Rep. 2017 Oct 10;21(2):508-516
pubmed: 29020635
Int J Mol Sci. 2018 Jan 18;19(1):
pubmed: 29346265
Cancers (Basel). 2020 May 08;12(5):
pubmed: 32397295
Theranostics. 2019 Apr 6;9(7):2056-2070
pubmed: 31037156
J Clin Oncol. 2010 Jan 1;28(1):29-34
pubmed: 19933915
Am J Respir Crit Care Med. 2005 Jun 1;171(11):1286-91
pubmed: 15750044
Eur J Pharmacol. 2008 Dec 28;601(1-3):23-9
pubmed: 18983839
Microsyst Nanoeng. 2021 Jun 21;7:50
pubmed: 34567763
IEEE Trans Med Imaging. 2013 Jul;32(7):1265-76
pubmed: 23549887
Clin Lung Cancer. 2016 Sep;17(5):466-469
pubmed: 27378174
Appl Biochem Biotechnol. 2014 Oct;174(3):880-96
pubmed: 24903961
Mol Cancer. 2023 Feb 21;22(1):40
pubmed: 36810079
IEEE Trans Ultrason Ferroelectr Freq Control. 2014 Jan;61(1):102-19
pubmed: 24402899
Sci Rep. 2018 Jan 18;8(1):1117
pubmed: 29348670
J Mol Diagn. 2013 Jul;15(4):415-53
pubmed: 23562183
Front Cell Dev Biol. 2021 Nov 16;9:740574
pubmed: 34869324
Eur Respir J. 2009 Jul;34(1):261-75
pubmed: 19567608
Nat Rev Cancer. 2022 Dec;22(12):679-692
pubmed: 36280768
Int J Radiat Oncol Biol Phys. 2015 Dec 1;93(5):989-96
pubmed: 26581137
Clin Cancer Res. 2015 Dec 15;21(24):5439-44
pubmed: 26672084
Hum Pathol. 1994 Jun;25(6):564-71
pubmed: 7912220
Pharmaceutics. 2021 Dec 28;14(1):
pubmed: 35056955
Redox Biol. 2017 Apr;11:653-662
pubmed: 28157665
Exp Hematol Oncol. 2022 Jul 30;11(1):44
pubmed: 35907881
Pathol Res Pract. 2022 Nov;239:154147
pubmed: 36228348
J Clin Oncol. 2010 Jul 1;28(19):3138-45
pubmed: 20516435
Sci Rep. 2020 Nov 9;10(1):19366
pubmed: 33168846
Biosensors (Basel). 2022 Jul 25;12(8):
pubmed: 35892460
ALTEX. 2002;19(2):73-8
pubmed: 12098013
Ann Biomed Eng. 2012 Jun;40(6):1255-67
pubmed: 22271245
Oncogene. 2021 Jan;40(1):1-11
pubmed: 33060857
Handb Exp Pharmacol. 2010;(197):87-112
pubmed: 20217527
Mol Med Rep. 2019 Dec;20(6):4803-4810
pubmed: 31638205
CA Cancer J Clin. 2018 Jan;68(1):7-30
pubmed: 29313949
Am J Clin Oncol. 2016 Feb;39(1):98-106
pubmed: 26558876
Biosensors (Basel). 2021 Feb 04;11(2):
pubmed: 33557033
Acta Inform Med. 2011 Sep;19(3):168-71
pubmed: 23408755
J Clin Oncol. 2013 Sep 20;31(27):3320-6
pubmed: 23980091
Sensors (Basel). 2022 Nov 25;22(23):
pubmed: 36501852
J Clin Oncol. 2017 Aug 10;35(23):2613-2618
pubmed: 28520527
Int J Mol Sci. 2022 Mar 03;23(5):
pubmed: 35269947
Curr Cancer Drug Targets. 2003 Aug;3(4):275-86
pubmed: 12871058
J Exp Clin Cancer Res. 2021 Jun 4;40(1):184
pubmed: 34088360
Cancer Cell Int. 2022 Nov 15;22(1):354
pubmed: 36376956
Curr Pharm Biotechnol. 2010 Jun;11(4):404-10
pubmed: 20199378
Lancet Oncol. 2013 Jan;14(1):38-47
pubmed: 23200175
Thorax. 2012 Apr;67(4):296-301
pubmed: 22286927
Occup Environ Med. 2007 Jan;64(1):5-6
pubmed: 17189454
JAMA Cardiol. 2018 Apr 1;3(4):346-350
pubmed: 29490335
Talanta. 2021 Apr 1;225:121986
pubmed: 33592734
Hematol Oncol Clin North Am. 2012 Jun;26(3):589-605, viii
pubmed: 22520981
Micromachines (Basel). 2022 Aug 29;13(9):
pubmed: 36144045
Nat Med. 2004 Aug;10(8):789-99
pubmed: 15286780
Chest. 2023 Mar;163(3):479-480
pubmed: 36894259
Ann Thorac Surg. 2009 Oct;88(4):1093-9
pubmed: 19766786
J Clin Oncol. 2009 Sep 10;27(26):4247-53
pubmed: 19667264
J Clin Invest. 2022 Apr 15;132(8):
pubmed: 35426374
Curr Cancer Drug Targets. 2015;15(7):604-12
pubmed: 26033086
Clin Lab Med. 1987 Jun;7(2):301-23
pubmed: 3301172
Micromachines (Basel). 2022 Jan 22;13(2):
pubmed: 35208289
Lancet Oncol. 2017 Dec;18(12):e754-e766
pubmed: 29208441
Biomed Microdevices. 2009 Aug;11(4):861-7
pubmed: 19353273
Curr Med Chem. 2016;23(20):2112-31
pubmed: 27160536
Immunity. 2020 Jan 14;52(1):17-35
pubmed: 31940268
Expert Rev Mol Diagn. 2006 Mar;6(2):231-44
pubmed: 16512782
N Engl J Med. 2016 Nov 10;375(19):1823-1833
pubmed: 27718847
Cent Eur J Immunol. 2022;47(2):168-174
pubmed: 36751395
Nature. 2018 Jan 24;553(7689):446-454
pubmed: 29364287
J Leukoc Biol. 2013 Jul;94(1):41-53
pubmed: 23667165
Micromachines (Basel). 2020 Oct 12;11(10):
pubmed: 33053796
IEEE Trans Ultrason Ferroelectr Freq Control. 2013 Sep;60(9):1853-67
pubmed: 24626107
Front Immunol. 2021 Nov 01;12:782775
pubmed: 34790207
Contemp Oncol (Pozn). 2021;25(1):45-52
pubmed: 33911981
Cancer Treat Rev. 2015 May;41(5):401-11
pubmed: 25842168
Int J Mol Sci. 2011;12(6):3648-704
pubmed: 21747700
Lung Cancer. 2019 Aug;134:108-116
pubmed: 31319968
Microsyst Nanoeng. 2022 Jul 7;8:77
pubmed: 35812806
Int J Mol Sci. 2017 Nov 27;18(12):
pubmed: 29186904
Nat Commun. 2022 Jun 9;13(1):3195
pubmed: 35680898
N Engl J Med. 2020 Jan 2;382(1):41-50
pubmed: 31751012
Int J Occup Environ Health. 2014 Apr-Jun;20(2):95-114
pubmed: 24999845
Proc Natl Acad Sci U S A. 2021 Jul 6;118(27):
pubmed: 34210796
Front Bioeng Biotechnol. 2020 Jul 29;8:827
pubmed: 32850709
Ann Oncol. 2023 Apr;34(4):358-376
pubmed: 36669645
Sensors (Basel). 2018 Oct 28;18(11):
pubmed: 30373306
Methods Mol Biol. 2020;2059:191-205
pubmed: 31435922
Curr Drug Metab. 2019;20(6):416-429
pubmed: 30227814
Int J Breast Cancer. 2011;2011:831605
pubmed: 22295234
Sensors (Basel). 2019 Jan 12;19(2):
pubmed: 30642060
Lancet Respir Med. 2018 Dec;6(12):915-924
pubmed: 30442588
Cancer Invest. 2020 Feb;38(2):85-93
pubmed: 31939681
J Clin Med. 2023 Feb 16;12(4):
pubmed: 36836096
N Engl J Med. 2018 Feb 22;378(8):731-739
pubmed: 29466156
Respir Med. 2012 Feb;106(2):173-83
pubmed: 22104541
PLoS Med. 2005 Jan;2(1):e17
pubmed: 15696205
Sci Rep. 2022 Aug 4;12(1):13386
pubmed: 35927389
Cancers (Basel). 2023 Feb 14;15(4):
pubmed: 36831559
Immunity. 2004 Aug;21(2):137-48
pubmed: 15308095
Animal Model Exp Med. 2021 Mar 29;4(2):87-103
pubmed: 34179717
Curr Chall Thorac Surg. 2023 Feb 25;5:
pubmed: 37016707
Biosensors (Basel). 2020 Jul 25;10(8):
pubmed: 32722438
J Clin Oncol. 2015 Dec 1;33(34):4007-14
pubmed: 26324372
Eur J Pharm Biopharm. 2021 Jun;163:198-211
pubmed: 33852968
Adv Drug Deliv Rev. 2012 Nov;64(14):1628-38
pubmed: 22926321
Adv Sci (Weinh). 2021 Mar 08;8(10):2004990
pubmed: 34026463
Adv Biochem Eng Biotechnol. 2022;179:247-265
pubmed: 32435872
J Am Chem Soc. 2012 Dec 5;134(48):19532-5
pubmed: 23148416
Cancers (Basel). 2021 Apr 27;13(9):
pubmed: 33925308
Nanomicro Lett. 2022 Apr 11;14(1):100
pubmed: 35403935
Transl Res. 2021 Apr;230:164-196
pubmed: 33253979
Nat Rev Cancer. 2020 Jun;20(6):343-354
pubmed: 32341552
Sci Adv. 2022 Apr;8(13):eabm9845
pubmed: 35363511
Lancet. 2014 May 3;383(9928):1561-71
pubmed: 24576776
Cell Stem Cell. 2018 Mar 1;22(3):310-324
pubmed: 29499151
Biology (Basel). 2021 Sep 03;10(9):
pubmed: 34571741
Talanta. 2021 Apr 1;225:122002
pubmed: 33592810
N Engl J Med. 2018 Dec 13;379(24):2342-2350
pubmed: 30280658
ACS Appl Mater Interfaces. 2018 Dec 19;10(50):43375-43386
pubmed: 30451486
Int J Pharm Investig. 2013 Jan;3(1):8-14
pubmed: 23799201
ACS Appl Mater Interfaces. 2016 Oct 5;8(39):25840-25847
pubmed: 27606718
Nanotheranostics. 2022 Jan 1;6(1):62-78
pubmed: 34976581
J Clin Oncol. 2013 Mar 10;31(8):1097-104
pubmed: 23401445
Ann Oncol. 2015 May;26(5):894-901
pubmed: 25722381
Cancers (Basel). 2021 Aug 05;13(16):
pubmed: 34439103
Micromachines (Basel). 2020 Jan 03;11(1):
pubmed: 31947894
Hum Gene Ther Methods. 2014 Feb;25(1):57-71
pubmed: 24164605
Nat Biomed Eng. 2019 Mar;3(3):220-229
pubmed: 30948808
Lab Chip. 2018 Jan 30;18(3):486-495
pubmed: 29309077
Int J Cancer. 2017 Feb 1;140(3):662-673
pubmed: 27750381
J Breath Res. 2019 Mar 06;13(2):024001
pubmed: 30620934
Signal Transduct Target Ther. 2016 Jan 28;1:15004
pubmed: 29263891
Am J Cancer Res. 2015 Aug 15;5(9):2892-911
pubmed: 26609494
Biosensors (Basel). 2022 Dec 29;13(1):
pubmed: 36671890
Drug Deliv. 2016;23(1):1-11
pubmed: 24758139
Cancer Res. 2001 Dec 15;61(24):8887-95
pubmed: 11751413
Diagnostics (Basel). 2022 Jul 01;12(7):
pubmed: 35885514
Curr Cancer Drug Targets. 2003 Aug;3(4):239-50
pubmed: 12871055
Nat Rev Cancer. 2008 Jun;8(6):473-80
pubmed: 18469827
Nat Biotechnol. 2014 Aug;32(8):760-72
pubmed: 25093883
Nat Rev Cancer. 2021 Jun;21(6):345-359
pubmed: 33837297
Transl Lung Cancer Res. 2021 Jan;10(1):607-621
pubmed: 33569340
J Pharm Pharm Sci. 2000 May-Aug;3(2):234-58
pubmed: 10994037
J Breath Res. 2012 Jun;6(2):027108
pubmed: 22621865
J Control Release. 2012 Apr 10;159(1):14-26
pubmed: 22154931
Nat Commun. 2023 Feb 27;14(1):1103
pubmed: 36843156
Biosens Bioelectron. 2021 Mar 15;176:112905
pubmed: 33358285
J Thorac Oncol. 2017 Oct;12(10):1544-1551
pubmed: 28709937
J Control Release. 2016 Sep 28;238:197-211
pubmed: 27469471
Biosens Bioelectron. 2001 Jan;16(1-2):121-31
pubmed: 11261847
Nat Commun. 2022 Jun 2;13(1):3086
pubmed: 35654785
J Clin Oncol. 2008 Nov 1;26(31):5043-51
pubmed: 18809614
Clin Cancer Res. 2013 Aug 1;19(15):4273-81
pubmed: 23729361
Oncotarget. 2018 Aug 14;9(63):32182-32190
pubmed: 30181808
Nat Rev Immunol. 2020 Nov;20(11):651-668
pubmed: 32433532
J Breath Res. 2018 Nov 20;13(1):016006
pubmed: 30221629
Interact Cardiovasc Thorac Surg. 2013 Mar;16(3):244-9
pubmed: 23169877
Ann Thorac Surg. 2016 Jan;101(1):238-44; discussion 44-5
pubmed: 26428690
Chest. 2003 Jun;123(6):2115-23
pubmed: 12796197
Nature. 2007 Mar 8;446(7132):145-6
pubmed: 17344839
J Thorac Oncol. 2010 Feb;5(2):220-8
pubmed: 20027124
Eur J Hosp Pharm. 2023 Jan;30(1):3-8
pubmed: 34497128
N Engl J Med. 2019 Nov 21;381(21):2020-2031
pubmed: 31562796
IEEE Trans Ultrason Ferroelectr Freq Control. 2019 Aug;66(8):1316-1330
pubmed: 31180847
J Biomol Struct Dyn. 2023 Mar 30;:1-14
pubmed: 36995235
IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Dec;52(12):2276-88
pubmed: 16463493
Sci Rep. 2021 Jan 28;11(1):2520
pubmed: 33510214
Phys Med Biol. 2019 Apr 23;64(9):095003
pubmed: 30917360
Lancet Oncol. 2017 Dec;18(12):1610-1623
pubmed: 29129443
J Thorac Oncol. 2016 May;11(5):613-638
pubmed: 27013409
Micromachines (Basel). 2023 Feb 02;14(2):
pubmed: 36838074
J Aerosol Med Pulm Drug Deliv. 2008 Mar;21(1):61-70
pubmed: 18518832
CA Cancer J Clin. 2023 Jan;73(1):17-48
pubmed: 36633525
Lancet. 2017 Jan 21;389(10066):299-311
pubmed: 27574741
Essays Biochem. 2016 Jun 30;60(1):1-8
pubmed: 27365030
Sensors (Basel). 2012;12(3):2742-65
pubmed: 22736975
Lancet Oncol. 2016 Jul;17(7):984-993
pubmed: 27283860
IEEE Trans Ultrason Ferroelectr Freq Control. 2009 Mar;56(3):489-506
pubmed: 19411209
J Clin Oncol. 2008 Jul 20;26(21):3552-9
pubmed: 18506026
J Breath Res. 2018 Oct 30;13(1):016003
pubmed: 30045999
Chest. 2023 Mar;163(3):697-706
pubmed: 36243060
Semin Oncol. 2010 Oct;37(5):430-9
pubmed: 21074057
Nature. 2007 Dec 6;450(7171):893-8
pubmed: 17982442
Ann Oncol. 2019 Jul 1;30(7):1121-1126
pubmed: 30980071
Biosens Bioelectron. 2023 Jul 1;231:115271
pubmed: 37060819
Cancer. 2017 Aug 15;123(16):3031-3039
pubmed: 28346656
J Biomed Biotechnol. 2012;2012:568567
pubmed: 22547927
N Engl J Med. 2015 Jul 9;373(2):123-35
pubmed: 26028407
Front Bioeng Biotechnol. 2016 Feb 12;4:12
pubmed: 26904541
Annu Rev Immunol. 2004;22:329-60
pubmed: 15032581
Ann N Y Acad Sci. 2013 May;1284:1-5
pubmed: 23651186
Sensors (Basel). 2020 Jul 03;20(13):
pubmed: 32635286
Front Oncol. 2018 Mar 28;8:86
pubmed: 29644214
Int J Cancer. 2006 Jan 15;118(2):257-62
pubmed: 16231326
Trends Cancer. 2016 Jul;2(7):350-364
pubmed: 27819059
Cancers (Basel). 2021 Sep 20;13(18):
pubmed: 34572931
J Natl Cancer Inst. 2005 Mar 2;97(5):339-46
pubmed: 15741570
Cancer Res Treat. 2022 Apr;54(2):315-329
pubmed: 35209703
PLoS One. 2019 Dec 16;14(12):e0226193
pubmed: 31841547
Lancet Oncol. 2019 Dec;20(12):1691-1701
pubmed: 31669155
Sensors (Basel). 2016 Aug 24;16(9):
pubmed: 27563912
Chem Commun (Camb). 2015 Apr 28;51(33):7100-3
pubmed: 25658236
J Thorac Oncol. 2021 May;16(5):860-867
pubmed: 33476803
Sensors (Basel). 2015 Apr 03;15(4):8020-41
pubmed: 25855038
Cancer. 2018 Feb 15;124(4):667-678
pubmed: 29266226
J Thorac Cardiovasc Surg. 2017 Jun;153(6):1592-1597
pubmed: 28274562
Anal Chem. 2010 Jul 1;82(13):5477-83
pubmed: 20550213
J Am Chem Soc. 2003 Nov 5;125(44):13559-63
pubmed: 14583053
Clin Cancer Res. 2015 Mar 1;21(5):1172-82
pubmed: 25549722
J Mol Diagn. 2003 May;5(2):103-12
pubmed: 12707375
World J Methodol. 2013 Dec 26;3(4):39-44
pubmed: 25237622
Nat Commun. 2020 Jul 21;11(1):3475
pubmed: 32694610
Neoplasia. 2016 Sep;18(9):577-83
pubmed: 27659017
Open Biol. 2017 Sep;7(9):
pubmed: 28878044
J Med Invest. 1997 Aug;44(1-2):15-24
pubmed: 9395713
Thorac Cancer. 2022 Apr;13(7):889-899
pubmed: 35289077
Int J Mol Sci. 2021 Mar 05;22(5):
pubmed: 33807876
Expert Rev Anticancer Ther. 2022 Feb;22(2):183-189
pubmed: 34989305
Clin Cancer Res. 1999 Dec;5(12):4242-8
pubmed: 10632366
Appl Sci (Basel). 2020 Oct 29;10(21):7655
pubmed: 33680504
Support Care Cancer. 2012 Nov;20(11):2639-47
pubmed: 22544223
Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4392s-4395s
pubmed: 16857816
Lung. 2020 Dec;198(6):897-907
pubmed: 33175991
Analyst. 2011 Apr 7;136(7):1288-97
pubmed: 21274478
Lancet Oncol. 2020 Feb;21(2):261-270
pubmed: 31838015
Biomaterials. 2014 Jul;35(22):5660-9
pubmed: 24746968
J Transl Med. 2022 May 10;20(1):206
pubmed: 35538576
Science. 2010 Jun 25;328(5986):1662-8
pubmed: 20576885
Adv Exp Med Biol. 2022;1379:499-524
pubmed: 35761005
Front Oncol. 2022 Jul 07;12:933125
pubmed: 35875155
Ultrason Sonochem. 2005 Jan;12(1-2):53-7
pubmed: 15474952
Macromol Biosci. 2011 Oct 10;11(10):1336-45
pubmed: 21823236
PLoS One. 2017 Sep 22;12(9):e0185293
pubmed: 28938010